SKI Market

A+| A| A-|

Indian Indices

Sensex

76,478.67 -249.70
( -0.33%)

Global Indices

Nasdaq

52,219.26 322.15
(0.62%)

Dow Jones

7,463.83 88.81
(1.20%)

Hang Seng

70,280.54 812.43
(1.17%)

Nikkei 225

10,511.26 27.04
(0.26%)

Forex

USD-INR

94.12 -0.28
(-0.30%)

EUR-INR

107.15 -0.14
(-0.13%)

GBP-INR

124.16 -0.32
(-0.26%)

JPY-INR

0.58 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01029

41.3479918

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

59.92

1644.06

EPS(TTM)

Face Value()

Div & Yield %

6.64

0.13

Back

Rubfila International consolidated net profit declines 30.90% in the December 2025 quarter

Feb 14,2026

Net profit of Rubfila International declined 30.90% to Rs 5.50 crore in the quarter ended December 2025 as against Rs 7.96 crore during the previous quarter ended December 2024. Sales rose 6.35% to Rs 146.73 crore in the quarter ended December 2025 as against Rs 137.97 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	146.73	137.97	6
OPM %	5.88	8.62	-
PBDT	10.28	13.46	-24
PBT	7.46	10.72	-30
NP	5.50	7.96	-31

76,478.67 -249.70 ( -0.33%)

52,219.26 322.15 (0.62%)

7,463.83 88.81 (1.20%)

70,280.54 812.43 (1.17%)

10,511.26 27.04 (0.26%)

94.12 -0.28 (-0.30%)

107.15 -0.14 (-0.13%)

124.16 -0.32 (-0.26%)

0.58 0.00 (-0.29%)